Viewing Study NCT06607757


Ignite Creation Date: 2025-12-24 @ 6:50 PM
Ignite Modification Date: 2026-01-04 @ 2:02 AM
Study NCT ID: NCT06607757
Status: RECRUITING
Last Update Posted: 2025-04-02
First Post: 2024-06-14
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Capivasertib Plus Fulvestrant vs. Fulvestrant in Primary High-risk Lobular Breast Cancer
Sponsor: GBG Forschungs GmbH
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module